Search

Your search keyword '"Bories, Claire"' showing total 31 results

Search Constraints

Start Over You searched for: Author "Bories, Claire" Remove constraint Author: "Bories, Claire"
31 results on '"Bories, Claire"'

Search Results

1. Momelotinib versus danazol in symptomatic patients with anaemia and myelofibrosis (MOMENTUM): results from an international, double-blind, randomised, controlled, phase 3 study

2. Familial myeloid malignancies with germline TET2 mutation

3. Mutational profiling of isolated myeloid sarcomas and utility of serum 2HG as biomarker of IDH1/2 mutations

4. Momelotinib versus danazol in symptomatic patients with anaemia and myelofibrosis (MOMENTUM): results from an international, double-blind, randomised, controlled, phase 3 study

7. Hidden in the Eyes—Recurrence of Systemic Hemopathies Reportedly “In Remission”: Six Cases and Review of Literature

9. Santé et produits de santé. Regards de la jeune doctrine Chaire DESAPS (2017-2021)

10. Lenalidomide is safe and active in Waldenström macroglobulinemia

11. Santé et produits de santé. Regards de la jeune doctrineChaire DESAPS (2017-2021)

13. Case Report: Two Cases of Cryptosporidiosis in Heavily Pretreated Patients With Myeloma

14. Familial myeloid malignancies with germline TET2 mutation

15. Daratumumab is effective in the relapsed or refractory systemic light‐chain amyloidosis but associated with high infection burden in a frail real‐life population

18. Discontinuation of antimicrobial therapy in adult neutropenic haematology patients: A prospective cohort

19. Response to pneumococcal vaccination in multiple myeloma

21. Efficacy and Safety of Daratumumab in a Frail Real-Life Relapsed or Refractory Systemic Light-Chain Amyloidosis Population (AL): Report on 15 Cases from the North of France

22. Daratumumab is effective in the relapsed or refractory systemic light‐chain amyloidosis but associated with high infection burden in a frail real‐life population.

24. Acquisition of genomic events leading to lymphoblastic transformation in a rare case of myeloproliferative neoplasm withBCR-JAK2fusion transcript

25. Can Assessment of Patient Monoclonal Immunoglobulins By Heavy/Light Analysis be Used to Assign Patient Responses Analogous to IMWG Response Criteria?

26. Time to Spare Newly Diagnosed Non Transplant Eligible Myeloma (eNDMM) from Thalidomide

27. Impact of Pneumococcal Vaccination on Multiple Myeloma

28. Comparison of Waldenstrom Macroglobulinemia Responses Using Immunoglobulin Heavy / Light Chain Analysis and Conventional Electrophoresis Techniques

29. Time to Spare Newly Diagnosed Non Transplant Eligible Myeloma from Thalidomide

30. Acquisition of genomic events leading to lymphoblastic transformation in a rare case of myeloproliferative neoplasm with BCR-JAK2 fusion transcript.

31. Hevylite, a Novel M-Component Based Biomarkers of Response to Therapy and Survival in Waldenstrom Macroglobulinemia

Catalog

Books, media, physical & digital resources